A carregar...

Concomitant (177)Lu-DOTATATE and capecitabine therapy in malignant paragangliomas

BACKGROUND: The role of concomitant peptide receptor radionuclide therapy (PRRT) and capecitabine therapy has shown benefit in gastroenteropancreatic neuroendocrine tumors. However, data reporting its role in paraganglioma (PGL) patients is lacking. The aim of this study was to evaluate the role of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EJNMMI Res
Main Authors: Yadav, Madhav Prasad, Ballal, Sanjana, Bal, Chandrasekhar
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6365580/
https://ncbi.nlm.nih.gov/pubmed/30725219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-019-0484-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!